home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  GENOME JAPAN  
  December 06, 2000

Biotechnology

 
     
  Cambridge Healthtech Institute, Tokyo, Japan
March 26-28, 2001


If there was any questions previously, the publication of the draft sequence for the human genome has made it very clear that genomics is going to play an increasingly critical role in the development of pharmaceuticals in the years to come. Such specialties as bioinformatics, gene expression monitoring, functional genomics, proteomics and pharmacogenomics will all need to be melded into efficient strategies to accelerate drug discovery and development. These tools are being brought to bear on the key applied tasks of target identification and validation, as well as clinical evaluation of compounds being developed. This conference brings together some of the leading examples of researchers from around the world who will discuss their experience and insight into these technologies, and the impact that new approaches can have on drug development.

 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Dr. Charlie Rodi, Sequenom, Inc.
Dr. Trevor Nicholls, Oxagen, Ltd.
Dr. Jan Michel, LION Bioscience AG
Dr. Andreas Duesterhoeft, QIAGEN Genomics, Inc.
Dr. Jacquelyn Fetrow, GeneFormatics, Inc.
 
Deadline for Abstracts: March 2, 2001
 
Registration: Available on-line
E-mail: jlaakso@healthtech.com
 
  Posted by:   Jennifer Laakso  
Host: wks217.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.